#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1040510	F	Agonist activity at TGR5 expressed in human U2-OS cells assessed as increase in MRE/CRE-driven gene expression by luciferase reporter gene assay		3		cell-based format	Scientific Literature
2.	ALA1040512	F	Increase in MRE/CRE-driven gene expression in human U2OS cells by luciferase reporter gene assay	Homo sapiens	3		cell-based format	Scientific Literature
3.	ALA1040513	P	Aqueous solubility of the compound		3		small-molecule physicochemical format	Scientific Literature
4.	ALA1040514	A	Permeability in artificial membrane assay		3		cell membrane format	Scientific Literature
5.	ALA1040516	F	Agonist activity at human TGR5 expressed in melanophores assessed as melanosome dispersion by melanophore assay	Homo sapiens	2		assay format	Scientific Literature
6.	ALA1040517	F	Agonist activity at rat TGR5 expressed in melanophores assessed as melanosome dispersion by melanophore assay	Rattus norvegicus	2		assay format	Scientific Literature
7.	ALA1040518	F	Agonist activity at canine TGR5 expressed in melanophores assessed as melanosome dispersion by melanophore assay	Canis lupus familiaris	2		assay format	Scientific Literature
8.	ALA1040519	F	Induction of melanosome dispersion in melanophores		2		cell-based format	Scientific Literature
9.	ALA1040523	A	Oral bioavailability in CD1 rat at 30 mg/kg	Rattus norvegicus	1		organism-based format	Scientific Literature
10.	ALA1040524	A	Volume of distribution at steady state in CD1 rat at 3 mg/kg, iv or 30 mg/kg, po	Rattus norvegicus	1		organism-based format	Scientific Literature
11.	ALA1040525	A	Clearance in CD1 rat at 3 mg/kg, iv or 30 mg/kg, po	Rattus norvegicus	1		organism-based format	Scientific Literature
12.	ALA1040526	A	Half life in CD1 rat at 3 mg/kg, iv or 30 mg/kg, po	Rattus norvegicus	1		organism-based format	Scientific Literature
13.	ALA1040528	A	Half life in dog at 3 mg/kg, iv or 30 mg/kg, po	Canis lupus familiaris	1		organism-based format	Scientific Literature
14.	ALA1040529	A	Clearance in dog at 3 mg/kg, iv or 30 mg/kg, po	Canis lupus familiaris	1		organism-based format	Scientific Literature
15.	ALA1040530	A	Volume of distribution at steady state in dog at 3 mg/kg, iv or 30 mg/kg, po	Canis lupus familiaris	1		organism-based format	Scientific Literature
16.	ALA1040531	A	Oral bioavailability in dog at 30 mg/kg	Canis lupus familiaris	1		organism-based format	Scientific Literature
17.	ALA1040532	A	Intrinsic clearance in rat hepatocytes	Rattus norvegicus	2		cell-based format	Scientific Literature
18.	ALA1040533	A	Intrinsic clearance in dog hepatocytes	Canis lupus familiaris	2		cell-based format	Scientific Literature
19.	ALA1040534	A	Inhibition of CYP2C19		2		single protein format	Scientific Literature
20.	ALA1040535	A	Inhibition of CYP3A4		2		single protein format	Scientific Literature